Altamira Therapeutics Ltd

NEW
FRA:2QA (Bermuda)  
€ 948 (0%) Jul 29
At Loss
P/B:
0.07
Market Cap:
€ 249.00K ($ 285.00K)
Enterprise V:
€ 940.00K ($ 1.08M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Altamira Therapeutics Ltd (FRA:2QA) Dividend

Altamira Therapeutics Ltd (FRA:2QA) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -401.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:2QA Dividend

Does Altamira Therapeutics Ltd (FRA:2QA) pay a dividend?

Altamira Therapeutics Ltd (FRA:2QA) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Altamira Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Altamira Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -401.3% over the past 3 years.

What are dividend-paying alternatives to Altamira Therapeutics Ltd?

For dividend-paying alternatives in Altamira Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.